InvestorsHub Logo
Followers 62
Posts 3932
Boards Moderated 0
Alias Born 12/21/2010

Re: muggel post# 4788

Monday, 01/26/2015 4:38:23 AM

Monday, January 26, 2015 4:38:23 AM

Post# of 6725
nice read
thanks

the new company has multiple options with early and novel candidates. Essentially, TKMR is on track to become an HBV basket in itself.



OnCore was founded in 2012 by the former Pharmasset management team and inventors of blockbuster hepatitis C drug, Sovaldi, shortly after Pharmasset’s sale to Gilead Sciences (GILD) for $11 billion. This is significant validation for Tekmira given the OnCore team’s history of success and experience with antivirals.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News